Analyzing the CRC cohort, the study reported reduced levels of CD36 in CRC, suggesting that CD36 appears to play a role in immune infiltration, with its levels positively correlating with infiltrating stromal scores in CRC [15]. The gene discussed is CD36; the disease is colorectal carcinoma.